Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of Pain

• Publication date

  2014-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jpain.2014.04.001PMID 24755282PMCID PMC4083500
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Disulfide-Containing High Mobility Group Box-1 Promotes N-Methyl-d-Aspartate Receptor Function and Excitotoxicity by Activating Toll-Like Receptor 4-Dependent Signaling in Hippocampal Neurons

  2014cited by this paper
• Spinal astrocyte gap junctions contribute to oxaliplatin-induced mechanical hypersensitivity.

  2013cited by this paper
• Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine

  2013cited by this paper
• Dexmedetomidine inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated macrophages in vitro.

  2013cited by this paper
• Induction of monocyte chemoattractant protein-1 (MCP-1) and its receptor CCR2 in primary sensory neurons contributes to paclitaxel-induced peripheral neuropathy.

  2013cited by this paper
• Targeting the Overproduction of Peroxynitrite for the Prevention and Reversal of Paclitaxel-Induced Neuropathic Pain

  2012cited by this paper
• The persistent release of HMGB1 contributes to tactile hyperalgesia in a rodent model of neuropathic pain

  2012cited by this paper
• Evidence that spinal astrocytes but not microglia contribute to the pathogenesis of Paclitaxel-induced painful neuropathy.

  2012cited by this paper
• Global Inhibition of Reactive Oxygen Species (ROS) Inhibits Paclitaxel-Induced Painful Peripheral Neuropathy

  2011cited by this paper
• Spinal Cord Toll-Like Receptor 4 Mediates Inflammatory and Neuropathic Hypersensitivity in Male But Not Female Mice

  2011cited by this paper
• Spinal TLR4 mediates the transition to a persistent mechanical hypersensitivity after the resolution of inflammation in serum‐transferred arthritis

  2011cited by this paper
• Metformin inhibits HMGB1 release in LPS‐treated RAW 264.7 cells and increases survival rate of endotoxaemic mice

  2011cited by this paper
• Protection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline.

  2011cited by this paper
• The response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries.

  2011cited by this paper
• HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells

  2011cited by this paper
• Intraepidermal nerve fiber loss corresponds to the development of Taxol‐induced hyperalgesia and can be prevented by treatment with minocycline

  2011cited by this paper
• Follow-up psychophysical studies in bortezomib-related chemoneuropathy patients.

  2011cited by this paper
• The Role of Glia and the Immune System in the Development and Maintenance of Neuropathic Pain

  2010cited by this paper
• Induction of high mobility group box‐1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury

  2010cited by this paper
• Induction of high mobility group box-1 in dorsal root ganglion contributes to pain hypersensitivity after peripheral nerve injury

  2010cited by this paper
• Schwann cell autophagy induced by SAHA, 17-AAG, or clonazepam can reduce bortezomib-induced peripheral neuropathy

  2010cited by this paper
• Cisplatin primes murine peritoneal macrophages for enhanced expression of nitric oxide, proinflammatory cytokines, TLRs, transcription factors and activation of MAP kinases upon co-incubation with L929 cells.

  2009cited by this paper
• Altered functional properties of satellite glial cells in compressed spinal ganglia

  2009cited by this paper
• Pathological and protective roles of glia in chronic pain

  2009cited by this paper
• Evidence for a role of heat shock protein-90 in toll like receptor 4 mediated pain enhancement in rats.

  2009cited by this paper
• The contributing role of CD14 in toll-like receptor 4 dependent neuropathic pain.

  2009cited by this paper
• Non‐stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll‐like receptor 4 (TLR4)

  2008cited by this paper
• How dying cells alert the immune system to danger

  2008cited by this paper
• Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy.

  2008cited by this paper
• Behavioral and electrophysiological studies in rats with cisplatin-induced chemoneuropathy.

  2008cited by this paper
• Glial TLR4 receptor as new target to treat neuropathic pain: Efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice

  2008cited by this paper
• Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain.

  2007cited by this paper
• The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling

  2007cited by this paper
• Stereological and somatotopic analysis of the spinal microglial response to peripheral nerve injury.

  2007cited by this paper
• Schwann cells: activated peripheral glia and their role in neuropathic pain.

  2007cited by this paper
• TLR-dependent Bim phosphorylation in macrophages is mediated by ERK and is connected to proteasomal degradation of the protein.

  2006cited by this paper
• Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy.

  2006cited by this paper
• Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells.

  2006cited by this paper
• Trigeminal Nociceptors Express TLR-4 and CD14: a Mechanism for Pain due to Infection

  2006cited by this paper
• Altered discharges of spinal wide dynamic range neurons and down-regulation of glutamate transporter expression in rats with paclitaxel-induced hyperalgesia.

  2006cited by this paper
• BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain

  2005cited by this paper
• The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy.

  2005cited by this paper
• Mechanism of taxane neurotoxicity

  2004cited by this paper
• Signal transduction by the lipopolysaccharide receptor, Toll‐like receptor‐4

  2004cited by this paper
• Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B.

  2004cited by this paper
• Taxol‐induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients

  2004cited by this paper
• Mal and MyD88: adapter proteins involved in signal transduction by Toll-like receptors

  2003cited by this paper
• Broad Expression of Toll‐Like Receptors in the Human Central Nervous System

  2002cited by this paper
• Control of synaptic strength by glial TNFalpha.

  2002cited by this paper
• Control of Synaptic Strength by Glial TNFα

  2002cited by this paper
• Anti-TNF-neutralizing antibodies reduce pain-related behavior in two different mouse models of painful mononeuropathy.

  2001cited by this paper
• The role of MyD88 and TLR4 in the LPS‐mimetic activity of Taxol

  2001cited by this paper
• Etanercept reduces hyperalgesia in experimental painful neuropathy

  2001cited by this paper
• Induction of proinflammatory and chemokine genes by lipopolysaccharide and paclitaxel (Taxol) in murine and human breast cancer cell lines.

  2001cited by this paper
• A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel

  2001cited by this paper
• Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain.

  2001cited by this paper
• Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat

  2000cited by this paper
• Cytokine‐mediated inflammatory hyperalgesia limited by interleukin‐1 receptor antagonist

  2000cited by this paper
• Possible role of inflammatory mediators in tactile hypersensitivity in rat models of mononeuropathy

  2000cited by this paper
• Upregulation And Interaction Of TNFα and Gelatinases A and B In Painful Peripheral Nerve Injury

  2000cited by this paper
• Upregulation and interaction of TNFalpha and gelatinases A and B in painful peripheral nerve injury.

  2000cited by this paper
• Acute peripheral inflammation induces moderate glial activation and spinal IL-1β expression that correlates with pain behavior in the rat

  1999cited by this paper
• Acute peripheral inflammation induces moderate glial activation and spinal IL-1beta expression that correlates with pain behavior in the rat.

  1999cited by this paper
• Unresponsiveness of MyD88-deficient mice to endotoxin.

  1999cited by this paper
• Hyperalgesia in experimental neuropathy is dependent on the TNF receptor 1.

  1998cited by this paper
• The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve

  1998cited by this paper
• Cytokines, nerve growth factor and inflammatory hyperalgesia: the contribution of tumour necrosis factor α

  1997cited by this paper
• Severe atypical neuropathy associated with administration of hematopoietic colony-stimulating factors and vincristine.

  1996cited by this paper
• Taxol and colchicine increase LPS-induced pro-IL-1 beta production, but do not increase IL-1 beta secretion. A role for microtubules in the regulation of IL-1 beta production.

  1995cited by this paper
• Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies

  1994cited by this paper
• Quantitative assessment of tactile allodynia in the rat paw.

  1994cited by this paper
• Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.

  1993cited by this paper
• Increased release of interleukin‐1 and tumour necrosis factor by interleukin‐2‐induced lymphokine‐activated killer cells in the presence of cisplatin and FK‐565

  1992cited by this paper
• Activation of human peripheral-blood-derived monocytes by cis-diamminedichloroplatinum: enhanced tumoricidal activity and secretion of tumor necrosis factor-alpha.

  1992cited by this paper
• Effect of cisplatin, rIFN-Y, LPS and MDP on release of H2O2, O2- and lysozyme from human monocytes in vitro.

  1991cited by this paper
• Shared actions of endotoxin and taxol on TNF receptors and TNF release.

  1990cited by this paper

• Targeting the oxidative stress-neuroinflammation axis: the mechanism of arctigenin’s broad-spectrum analgesia with limited side effects

  2026cites this paper
• Electroacupuncture at Zusanli (ST36) alleviates paclitaxel-induced neuropathic pain in rats via regulating TLR4 signaling pathway in the spinal cord

  2026cites this paper
• Modified Wen Luo Tong Alleviated Chemotherapy-Induced Peripheral Neuropathy via Regulating the CX3CL1/CX3CR1 Axis Through Inhibiting NF-κB and STAT3 Pathways

  2026cites this paper
• Near-infrared photobiomodulation can alleviate chemotherapy-induced peripheral neuropathy-associated sensory abnormalities

  2026cites this paper
• Mechanisms and Management of Albumin-Paclitaxel-Induced Peripheral Neuropathy in Breast Cancer

  2025cites this paper
• Preventive effect of RAGE antagonists on distal infraorbital nerve injury-induced pain behaviors of male and female mice.

  2025cites this paper
• Detection of probable neuronal gene expression changes in skin biopsies from patients with paclitaxel-induced peripheral neuropathy

  2025cites this paper
• Proneurotrophin-3 contributes to chemotherapy-induced neuropathic pain through TrkC-mediated CCL2 elevation in DRG neurons

  2025cites this paper
• Neurofilaments as Prognostic Biomarkers in the Assessment of the Risk of Advanced Taxane-Induced Neuropathy in Breast Cancer Patients—A Pilot Study

  2025cites this paper
• TLR4 deletion reduces small fiber sensory abnormalities and nerve degeneration in diabetic male mice.

  2025cites this paper
• Myeloid Differentiation Primary Response Protein 88: An Important Therapeutic Target for Chronic Pain

  2025cites this paper
• Chronic Pain Induced by Social Defeat Stress in Juvenile Mice Depends on TLR4

  2025cites this paper
• Paclitaxel-induced adverse effects: insights into multi-organ toxicities and molecular mechanisms

  2025cites this paper
• Leukocyte-intrinsic ER stress responses contribute to chemotherapy-induced peripheral neuropathy.

  2025cites this paper
• Ribosome profiling reveals that post-transcriptional control of Nalf1 by heterogeneous nuclear ribonucleoprotein L is required for paclitaxel-induced neuropathic pain.

  2025cites this paper
• Paclitaxel activates SOCE/ICRAC in dorsal root ganglion neurons: implications for paclitaxel-induced peripheral neuropathy.

  2025cites this paper
• Polyvalent immunoglobulin therapy: preclinical evidence and potential for treating chemotherapy-induced peripheral neuropathy

  2025cites this paper
• Glial Activation Enhances Spinal TRPV1 Receptor Sensitivity in a Paclitaxel Model of Neuropathic Pain

  2025cites this paper
• Design and synthesis of novel diclofenac-based quinazoline derivatives enhancing cisplatin and radiation impacts via MyD88 and COX-2/PGE2 modulation.

  2025cites this paper
• Roles of innate immune system and receptor Dectin-1 in synovium and cartilage homeostasis of osteoarthritis.

  2025cites this paper
• Mechanisms of spinal glial activation in chemotherapy‐induced peripheral neuropathy: Focus on microglia and astrocytes

  2025cites this paper
• Effect of glucagon-like peptide-1 receptor agonist on paclitaxel induced neurotoxicity in dorsal root ganglion neuronal cells in vitro

  2025cites this paper
• Targeting therapy-induced senescence as a novel strategy to combat chemotherapy-induced peripheral neuropathy

  2024cites this paper
• Protective Effects of Glatiramer Acetate Against Paclitaxel-Induced Peripheral Neuropathy in Rats: A Role for Inflammatory Cytokines and Oxidative Stress

  2024cites this paper
• WITHDRAWN ARTICLE: NT-3 contributes to chemotherapy-induced neuropathic pain through TrkC-mediated CCL2 elevation in DRG neurons

  2024cites this paper
• Evolution of snake skin: Role of cutaneous tactile corpuscles in Hierophis viridiflavus (Lacépède, 1789)

  2024cites this paper
• RNA-seq revealed the protective effect of Huangqi Guizhi Wuwu Decoction against cisplatin induced PC12 cell injury

  2024cites this paper
• Upregulation of NGF/TrkA-Related Proteins in Dorsal Root Ganglion of Paclitaxel-Induced Peripheral Neuropathy Animal Model

  2024cites this paper
• Cognitive function in long-term testicular cancer survivors: impact of modifiable factors

  2024cites this paper
• The Role of the Gut Microbiome in Neuroinflammation and Chemotherapy-Induced Peripheral Neuropathy.

  2024cites this paper
• Chemotherapy-Induced Peripheral Neuropathy: A Recent Update on Pathophysiology and Treatment

  2024cites this paper
• Paclitaxel triggers molecular and cellular changes in the choroid plexus

  2024cites this paper
• The influence of sex on neuroimmune communication, pain, and physiology

  2024cites this paper
• Electroacupuncture inhibits TLR4/NF-κB signaling in the dorsal root ganglion of rats with spared nerve injury

  2024cites this paper
• ApoA-I binding protein (AIBP) regulates transient receptor potential vanilloid 1 (TRPV1) activity in rat dorsal root ganglion neurons by selective disruption of toll-like receptor 4 (TLR4)-lipid rafts.

  2024cites this paper
• G-protein-coupled estrogen receptor 30 regulation of signaling downstream of protein kinase Cε mediates sex dimorphism in hyaluronan-induced antihyperalgesia.

  2024cites this paper
• Targeting dorsal root ganglia for chemotherapy-induced peripheral neuropathy: from bench to bedside

  2024cites this paper
• HDAC inhibitors as a potential therapy for chemotherapy-induced neuropathic pain

  2024cites this paper
• TLR-4: a promising target for chemotherapy-induced peripheral neuropathy

  2024cites this paper
• Modulation of chemotherapy-induced peripheral neuropathy by JZL195 through glia and the endocannabinoid system.

  2024cites this paper
• Role of pattern recognition receptors in chemotherapy-induced neuropathic pain.

  2023cites this paper
• The mechanistic basis for the effects of electroacupuncture on neuropathic pain within the central nervous system.

  2023cites this paper
• Hyperbaric Oxygen Therapy Alleviates Paclitaxel-Induced Peripheral Neuropathy Involving Suppressing TLR4-MyD88-NF-κB Signaling Pathway

  2023cites this paper
• Cannabidiol prevents chemotherapy-induced neuropathic pain by modulating spinal TLR4 via endocannabinoid system activation.

  2023cites this paper
• High-Frequency Electrical Stimulation Reduced Hyperalgesia and the Activation of the Myd88 and NFκB Pathways in Chronic Constriction Injury of Sciatic Nerve-Induced Neuropathic Pain Mice.

  2023cites this paper
• Trimetazidine alleviates paclitaxel-induced peripheral neuropathy through modulation of TLR4/p38/NFκB and klotho protein expression.

  2023cites this paper
• Fecal Microbiota Transplantation Alleviated Paclitaxel-Induced Peripheral Neuropathy by Interfering with Astrocytes and TLR4/p38MAPK Pathway in Rats

  2023cites this paper
• Roles of neuronal toll-like receptors in neuropathic pain and central nervous system injuries and diseases.

  2022cites this paper
• Pharmacologic Management of Persistent Pain in Cancer Survivors

  2022cites this paper
• New Vistas in microRNA Regulatory Interactome in Neuropathic Pain

  2022cites this paper
• Regulation of Neuroinflammatory Signaling by PPARγ Agonist in Mouse Model of Diabetes

  2022cites this paper
• PD-1/PD-L1 inhibition enhances chemotherapy-induced neuropathic pain by suppressing neuroimmune antinociceptive signaling.

  2022cites this paper
• AIBP regulates TRPV1 activation in chemotherapy-induced peripheral neuropathy by controlling lipid raft dynamics and proximity to TLR4 in dorsal root ganglion neurons.

  2022cites this paper
• Toll-like receptors in chronic pain

  2022cites this paper
• Intrathecal administration of bone marrow stromal cells and TGF-β1 alleviate chemotherapy-induced neuropathic pain in male mice

  2022cites this paper
• Emerging Roles of Toll-like Receptor 4 in Chemotherapy-induced Neurotoxicity.

  2022cites this paper
• Paclitaxel Regulates TRPA1 Function and Expression Through PKA and PKC

  2022cites this paper
• Specialized Pro-Resolving Mediators as Resolution Pharmacology for the Control of Pain and Itch.

  2022cites this paper
• Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial – Protocol of a multicenter, randomized, double-blind, placebo- controlled proof-of-concept phase-2 clinical trial

  2022cites this paper
• Dual PI3K d / c Inhibitor Duvelisib Prevents Development of Neuropathic Pain in Model of Paclitaxel-Induced Peripheral Neuropathy

  2022influential citation
• Sex Differences in Taxane Toxicities

  2022cites this paper
• Dual PI3Kδ/γ Inhibitor Duvelisib Prevents Development of Neuropathic Pain in Model of Paclitaxel-Induced Peripheral Neuropathy

  2022cites this paper
• The Role of Neuro-Immune Interactions in Chronic Pain: Implications for Clinical Practice

  2022cites this paper
• Shaoyao Gancao Decoction Ameliorates Paclitaxel-Induced Peripheral Neuropathy via Suppressing TRPV1 and TLR4 Signaling Expression in Rats

  2022cites this paper
• Neuroprotective Effects of Berbamine, Bergepten, and Carveol on Paclitaxel-Induced Peripheral Neuropathy

  2022cites this paper
• The role of T-lymphocytes in neuropathic pain initiation, development of chronicity and treatment

  2021cites this paper
• iPSCs and DRGs: stepping stones to new pain therapies.

  2021cites this paper
• Deletion of MyD88 adaptor in nociceptor alleviates low-dose formalin-induced acute pain and persistent pain in mice

  2021cites this paper
• Intrathecal Administration of an Anti‐nociceptive Non-CpG Oligodeoxynucleotide Reduces Glial Activation and Central Sensitization

  2021cites this paper
• Peripheral Mechanisms of Neuropathic Pain—The Role of Neuronal and Non-Neuronal Interactions and Their Implications for Topical Treatment of Neuropathic Pain

  2021cites this paper
• Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy

  2021cites this paper
• Neuroinflammatory Process Involved in Different Preclinical Models of Chemotherapy-Induced Peripheral Neuropathy

  2021cites this paper
• Antioxidants improve oxaliplatin-induced peripheral neuropathy in tumor-bearing mice model: role of spinal cord oxidative stress and inflammation.

  2021cites this paper
• Treatment of Established Chemotherapy-Induced Peripheral Neuropathy: Basic Science and Animal Models

  2021cites this paper
• Effects of chemotherapy for acute lymphoblastic leukemia on cognitive function in animal models of contemporary protocols: A systematic literature review.

  2021cites this paper
• Ketogenic diet prevents paclitaxel‐induced neuropathic nociception through activation of PPARγ signalling pathway and inhibition of neuroinflammation in rat dorsal root ganglion

  2021cites this paper
• Herbal formula Huangqi Guizhi Wuwu decoction attenuates paclitaxel-related neurotoxicity via inhibition of inflammation and oxidative stress

  2021cites this paper
• Redox-sensitive TRP channels: a promising pharmacological target in chemotherapy-induced peripheral neuropathy

  2021cites this paper
• Neuro-immune interactions in paclitaxel-induced peripheral neuropathy

  2021cites this paper
• Dorsal root ganglion toll-like receptor 4 signaling contributes to oxaliplatin-induced peripheral neuropathy.

  2021cites this paper
• Sensory neuron–associated macrophages as novel modulators of neuropathic pain

  2021cites this paper
• Simultaneous hyperbaric oxygen therapy during systemic chemotherapy reverses chemotherapy-induced peripheral neuropathy by inhibiting TLR4 and TRPV1 activation in the central and peripheral nervous system

  2021influential citation
• Role of innate immunity in chemotherapy-induced peripheral neuropathy.

  2021cites this paper
• Flavonoids Alleviate Peripheral Neuropathy Induced by Anticancer Drugs

  2021cites this paper
• Neuroimmune Consequences of eIF4E Phosphorylation on Chemotherapy-Induced Peripheral Neuropathy

  2021cites this paper
• Acupuncture for Paclitaxel-Induced Peripheral Neuropathy: A Review of Clinical and Basic Studies

  2021influential citation
• Review of the Role of the Brain in Chemotherapy-Induced Peripheral Neuropathy

  2021cites this paper
• Approach to chemotherapy-induced peripheral neuropathy

  2021cites this paper
• Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment

  2021cites this paper
• Role of high‐mobility group box 1 and its modulation by thrombomodulin/thrombin axis in neuropathic and inflammatory pain

  2020cites this paper
• Time Course of Peripheral and Central Immune System Alterations in Paclitaxel-Treated Mice: Possible Involvement of Dysfunctional Microglia

  2020cites this paper
• Paclitaxel Induces Upregulation of Transient Receptor Potential Vanilloid 1 Expression in the Rat Spinal Cord

  2020cites this paper
• Recent advances in understanding chemotherapy-induced peripheral neuropathy

  2020cites this paper
• Postoperative pain pathophysiology and treatment strategies after CRS + HIPEC for peritoneal cancer

  2020cites this paper
• Targeting interleukin-20 alleviates paclitaxel-induced peripheral neuropathy.

  2020cites this paper
• Electroacupuncture Treatment Attenuates Paclitaxel-Induced Neuropathic Pain in Rats via Inhibiting Spinal Glia and the TLR4/NF-κB Pathway

  2020cites this paper
• αvβ3 Integrin Antagonists Enhance Chemotherapy Response in an Orthotopic Pancreatic Cancer Model

  2020cites this paper
• The ambiguity of opioids revealed by Immunology is changing the knowledge and the therapeutic approach in cancer and non-cancer pain: A narrative review.

  2020cites this paper
• Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy

  2020cites this paper
• Role of CGRP in Neuroimmune Interaction via NF-κB Signaling Genes in Glial Cells of Trigeminal Ganglia

  2020cites this paper